These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3513030)

  • 41. [Drug resistance of Mycobacterium tuberculosis in coniotuberculosis].
    Beskrovnyĭ PS; Varenko IuS; Lastkov OA
    Vrach Delo; 1981 Aug; (8):72-4. PubMed ID: 6791383
    [No Abstract]   [Full Text] [Related]  

  • 42. [Combined use of various secondary antitubercular agents].
    Kekkaku; 1968 Mar; 43(3):45-7. PubMed ID: 4877917
    [No Abstract]   [Full Text] [Related]  

  • 43. Present aspects of genitourinary tuberculosis.
    Lattimer JK; Ehrlich RM
    Bibl Tuberc; 1968; 24():32-62. PubMed ID: 4983195
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pharmacological bases of tuberculosis chemotherapy].
    Kradolfer F
    Z Allgemeinmed; 1972 Sep; 48(25):1099-106. PubMed ID: 5083368
    [No Abstract]   [Full Text] [Related]  

  • 45. [Intermittent method of treatment of patients with pulmonary tuberculosis showing poor tolerance of antitubercular agents].
    Sushkin AG
    Vrach Delo; 1973 Nov; 11():94-7. PubMed ID: 4786944
    [No Abstract]   [Full Text] [Related]  

  • 46. [Terminal causes of death in patients suffering from pulmonary tuberculosis in relation to the drug sensitivity of the strains of Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Rossi P; Sbampato M; Storniello G
    Ann Ist Carlo Forlanini; 1969; 29(4):339-48. PubMed ID: 5004332
    [No Abstract]   [Full Text] [Related]  

  • 47. [Kidney function in intravenous chemotherapy for urogenital tuberculosis].
    Borisova-Kromenko VM; Maletin AG; Iakovets EM; Skudarnova TI
    Probl Tuberk; 1978 Feb; (2):45-7. PubMed ID: 643867
    [No Abstract]   [Full Text] [Related]  

  • 48. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects].
    Nitti V
    Arch Monaldi; 1972; 27(4):454-74. PubMed ID: 4217601
    [No Abstract]   [Full Text] [Related]  

  • 49. [The chemotherapy of tuberculosis].
    Mitchison DA
    Cas Lek Cesk; 1984 Feb; 123(6):145-52. PubMed ID: 6697362
    [No Abstract]   [Full Text] [Related]  

  • 50. [A method for the determination of the resistance of Mycobacterium tuberculosis to classical antitubercular drugs in percentages].
    Zduńczyk-Pawelek H; Kostrzewska K; Blitek-Golc D
    Gruzlica; 1966 Feb; 34(2):89-94. PubMed ID: 4957541
    [No Abstract]   [Full Text] [Related]  

  • 51. Tuberculosis in Acukland.
    Swinburn PD
    N Z Med J; 1973 Dec; 78(505):520-5. PubMed ID: 4205888
    [No Abstract]   [Full Text] [Related]  

  • 52. [Incidence of primary resistance to antitubercular agents in the Toulouse area].
    Puel J; Galtier M; Lareng MB; Delaude A
    Arch Monaldi; 1972; 27(4):418-25. PubMed ID: 4217598
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical study on tuberactinomycin, a new antibiotic].
    Osato T; Toyoara M
    Kekkaku; 1971 May; 46(3):59-63. PubMed ID: 4324041
    [No Abstract]   [Full Text] [Related]  

  • 54. [Tuberculosis chemotherapy in cases of resistance].
    Troi K; Marcocci S
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():477-8. PubMed ID: 6417641
    [No Abstract]   [Full Text] [Related]  

  • 55. [Recommendations for the therapy of tuberculosis].
    Eule H; Ganguin HG
    Z Erkr Atmungsorgane; 1984; 163(1):80-91. PubMed ID: 6485398
    [No Abstract]   [Full Text] [Related]  

  • 56. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapy of urogenital tuberculosis. German Society of Urology].
    Urologe A; 1997 Sep; 36(5):493-6. PubMed ID: 9424804
    [No Abstract]   [Full Text] [Related]  

  • 58. [Evolution of acquired drug resistance of Mycobacterium tuberculosis. Studies made in the period 1963-1965 at the Clinica Tisiologica of the University of Milan].
    Mandler F; Pradella F; Lucchini L; Ganzetti GL
    Minerva Med; 1968 Mar; 59(18):997-1001. PubMed ID: 5646215
    [No Abstract]   [Full Text] [Related]  

  • 59. [Tuberculostatic test in the treatment of pulmonary tuberculosis with 1st and 2d class drugs].
    Gur'ian IE; Svitneva AS; Tarasova EF
    Probl Tuberk; 1971; 49(12):33-6. PubMed ID: 5003602
    [No Abstract]   [Full Text] [Related]  

  • 60. [Characteristics of the course of pulmonary tuberculosis caused by Mycobacterium bovis].
    Kochetov BI; Dolzhanskiĭ VM; Nemsadze MN
    Probl Tuberk; 1980 Feb; (2):23-6. PubMed ID: 6990406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.